Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on July 9, 2025

Healthcare Boss Academy Founder Jason Duprat Seeks FANA Board of Directors Position to Advance Florida CRNA Interests

Healthcare Boss Academy Founder Jason Duprat Seeks FANA Board of Directors Position to Advance Florida CRNA Interests

Accomplished Healthcare Entrepreneur and Former Navy Officer Brings Proven Leadership Experience to Strengthen Professional Advocacy ORLANDO, FL, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- Healthcare Boss Academy announced its strong support for …

El Programa de Enfermería de SABER College Obtiene Acreditación Nacional de la NLN CNEA

El Programa de Enfermería de SABER College Obtiene Acreditación Nacional de la NLN CNEA

Este Reconocimiento Resalta el Compromiso de SABER College con la Excelencia Académica, el Éxito Estudiantil y el Desarrollo de la Fuerza Laboral de Enfermería MIAMI, FL, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- SABER College se enorgullece en …

SABER College Nursing Program Earns Initial National Accreditation from NLN CNEA

SABER College Nursing Program Earns Initial National Accreditation from NLN CNEA

Recognition Highlights SABER College’s Commitment to Academic Excellence, Student Success, and Nursing Workforce Development MIAMI, FL, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- SABER College proudly announces that its Associate Degree in …

COPILOT Appoints Leslie Donato to Board of Directors

COPILOT Appoints Leslie Donato to Board of Directors

COPILOT Strengthens Its Board with Industry Leader Known for Transformational Growth and Operational Excellence MAITLAND FL, FL, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- COPILOT, a leader in transforming patient access and support solutions for …

ChristianRehabs.com Relaunches its Platform to Support Clients in Finding Faith-Based Recovery Programs

ChristianRehabs.com Relaunches its Platform to Support Clients in Finding Faith-Based Recovery Programs

Newly Relaunched ChristianRehabs.com Offers Trusted Resources on Christian Rehab Placement and Faith-Based Program Support Backed by the Sober Network DELRAY BEACH, FL, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- The Sober Network, a long-standing …

AleYoga Launches Spanish-Language Yoga Programs for Beginners (Yoga para principiantes)

AleYoga Launches Spanish-Language Yoga Programs for Beginners (Yoga para principiantes)

MIAMI, FL, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- As more people across the U.S. and Latin America seek accessible wellness practices, AleYoga.com is stepping up to serve Spanish-speaking audiences with a structured and supportive approach to …

Pace Palm Beach Awarded $3,700 Grant from Mary’s Memorial Fund to Support Launch of Psychoeducation Groups Program

Pace Palm Beach Awarded $3,700 Grant from Mary’s Memorial Fund to Support Launch of Psychoeducation Groups Program

Mary’s Memorial Fund Grant will Help Pace Palm Beach Expand Access to Mental Health Programs for Girls PALM SPRINGS, FL, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- Pace Center for Girls Palm Beach recently received a generous $3,700 grant from …

Mobility City Delivers Fast, Reliable Mobility Equipment Repairs to Veterans Nationwide

Mobility City Delivers Fast, Reliable Mobility Equipment Repairs to Veterans Nationwide

Driven by Urgency | Trusted for Quality Repairs | Helping Veterans Improve their Quality of Life BOCA RATON, FL, UNITED STATES, July 9, 2025 /⁨EINPresswire.com⁩/ -- Mobility City, the leading network providing repair service for mobility and accessibility …

Gozellix Receives Permanent HCPCS Code

Gozellix Receives Permanent HCPCS Code

MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that its next-generation PSMA1 PET2 imaging agent, Gozellix® (kit for the preparation of gallium-68 ( …

Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

BOSTON, July 09, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to transforming the lives of patients living with rare neuroendocrine diseases, today announced …

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

RADNOR, Pa., July 09, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2025 after the market close on Wednesday, …

Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance

Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance

Jason Campagna, MD, PhD, joins Inventiva as President of R…

Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité

Inventiva annonce la nomination de Jason Campagna en tant que Président de la R&D et Directeur Médical et de Martine Zimmermann en tant que Vice-Présidente Exécutive en charge des affaires réglementaires et de l’assurance qualité

Jason Campagna, MD, PhD, rejoint Inventiva en tant que Président de la R…

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN FRANCISCO, July 09, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and …

Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis

Ultragenyx and Mereo BioPharma Announce UX143 Phase 3 Orbit Study for Osteogenesis Imperfecta Progressing to Final Analysis

NOVATO, Calif., July 09, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) and Mereo BioPharma Group plc (NASDAQ: MREO), today announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 ( …

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine

The previously disclosed and now published RESILIENT data show that once-nightly TNX-102 SL achieved statistically significant improvement in the primary endpoint of reducing fibromyalgia pain versus placebo, and was generally well tolerated These results …

Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and Waldenström macroglobulinemia (WM) Secured $15M license …

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …

OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation

OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation

OXFORD, United Kingdom and MADISON, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd., a leading organ medical technology company, has been announced as the winner of the prestigious 2025 MacRobert Award by the Royal Academy of Engineering. The award, …

Advanced Materials Market in Focus: BCC Research Publishes 2024 Sector Review

Advanced Materials Market in Focus: BCC Research Publishes 2024 Sector Review

Boston, July 09, 2025 (GLOBE NEWSWIRE) -- BCC Research announces the release of its " 2024 Advanced Materials Research Review," offering a deep dive into one of today’s most dynamic and fast-growing markets. This comprehensive report explores the latest …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service